Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?

Nora Hilda Hernandez Garcilazo, MD, Mohamed Hassanein, MD, Tushar J. Vachharajani, MD and Evamaria Anvari, MD
Cleveland Clinic Journal of Medicine August 2021, 88 (8) 431-433; DOI: https://doi.org/10.3949/ccjm.88a.20173
Nora Hilda Hernandez Garcilazo
Department of Internal Medicine, Michigan State University, East Lansing, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Mohamed Hassanein
Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tushar J. Vachharajani
Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
Evamaria Anvari
Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A 45-year-old man is admitted to the hospital for sepsis secondary to osteomyelitis. He has diabetes mellitus, hypertension, and stage 3 chronic kidney disease (CKD), with a glomerular filtration rate of 46 mL/min/1.73m2. He is treated with intravenous (IV) antibiotics and improves clinically. He will need 6 weeks of IV antibiotics after discharge. Should a peripherally inserted central catheter (PICC) be placed for IV access?

The decision to place a PICC must be individualized for the patient. Current guidelines do not provide explicit contraindications for creating permanent vascular access, but the general consensus is that poor candidates include those with advanced dementia, left ventricular ejection fraction less than 20%, poor vasculature on imaging, or terminal illness (life expectancy < 6–12 months).1 In addition, national guidelines and the American Board of Internal Medicine’s Choosing Wisely initiative recommend against PICC placement in patients expected to need permanent dialysis access in the future (CKD stages 3–5).2

PICC PROS: CONVENIENCE, LOW COST

PICCs have become increasingly popular in recent years due to their ease of placement, convenience for patients, and cost-effective maintenance. Up to 56% of PICCs are placed to administer IV antibiotics.3

PICC CONS: BLOOD VESSEL RISKS

PICCs are highly associated with phlebitis, thromboembolism, central vein thrombosis, and stenosis of the involved vessels, which may obliterate the involved veins and prevent their use for future creation of a permanent dialysis access.4 Clinically diagnosed thrombosis has been reported to occur in 1% to 4% of patients with a PICC. However, in a 2000 study using venography to evaluate patency of the vessels, Allen et al5 reported a much higher incidence, with thrombosis evident in 23.3% of patients after PICC insertion.

Higher rates of thrombosis are associated with larger catheter sizes, the use of cephalic veins (due to smaller size compared with basilic veins), greater number of lumens, placement of multiple catheters, and patient factors including malignancy or history of venous thromboembolism.5,6 Central venous stenosis may also occur, although it is not as common as thrombosis.7

PICC insertion is also a strong independent risk factor for failure of an arteriovenous fistula, the preferred method of vascular access for hemodialysis.7 McGill et al,8 in a 2016 observational study, found that PICC insertion before or after initiation of hemodialysis was associated with failure to transition to a form of permanent access, with only 24.7% of patients transitioning to a working arteriovenous fistula, and 11.5% transitioning to a functioning arteriovenous graft. This is very important because the transition from central venous access to an arteriovenous fistula or graft is associated with better survival and fewer hospitalizations, due to lower risk of serious infections such as endocarditis and bacteremia.8

In patients such as our 45-year-old man, an end-stage kidney disease (ESKD) life plan should be created with input from a nephrologist to determine early access needs and to avoid unnecessary procedures and complications, while also considering life expectancy and kidney replacement alternatives.2

CASE CONTINUED

The team decides to place a PICC through the right basilic vein (Figure 1), and the infection resolves with 6 weeks of IV antibiotics.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

A peripherally inserted central catheter (left) is inserted at the right basilic vein, through the axillary and subclavian veins and into the superior vena cava. The midline catheter (right) is also inserted at the right basilic vein with the tip just below the axilla.

However, 4 months later, he is readmitted for acute kidney injury and recurrence of osteomyelitis with a paravertebral abscess. The abscess is surgically drained, and the infectious disease consult recommends 8 weeks of IV antibiotics. After a thorough discussion with the nephrology team and the patient, the decision is made against placing a PICC.

PICC ALTERNATIVES

Unfortunately, all methods of IV access can produce venous damage, either by direct trauma at the puncture site or by device contact along the walls of the vein.9 It has been hypothesized that the more area within a vessel that a foreign object occupies, the greater the possibility of thrombosis due to increased stasis and direct-contact damage.3 However, midline catheters, which are also inserted into peripheral veins but occupy a smaller ending near the axilla, have also been associated with symptomatic venous thrombosis.4 Catheter location plays an important role, with guidelines suggesting avoiding cephalic, basilic, brachial, and subclavian veins.2,4

A proposed alternative to a PICC is a small-bore, 4-French or 6-French tunneled internal jugular catheter (Figure 2). It tends to last longer and is associated with fewer complications, decreasing the risk of central venous stenosis.10,11 A 2017 retrospective study by Bhutani et al10 found lower rates of deep vein thrombosis in tunneled small-bore central venous catheters than with PICCs, which may be explained by the shorter length of the catheter and better catheter-to-vein size ratio. However, whether they produce less damage to the peripheral vessels or cause central vein stenosis has not been fully studied.1

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

A small-bore (Hohn) catheter placed in the internal jugular vein is an alternative to a peripherally inserted central catheter.

It has also been suggested that placement of internal jugular catheters by a skilled proceduralist with ultrasonographic and fluoroscopic guidance may result in less venous trauma, reducing the risk of vessel stenosis compared with nonguided methods.11

But even after an arteriovenous fistula has been successfully created, patients with ESKD requiring hemodialysis must continue vessel-preservation strategies as part of their ESKD management plan.1 If IV antibiotics are needed, it may be possible to select an agent that can be administered 3 times a week on dialysis days, using the functioning hemodialysis access. This will avoid the need for a different catheter, decreasing the risk of central venous stenosis and allowing for the creation of other arteriovenous fistulas if the current one fails.3

Lifelong vessel-preservation strategies

Patients who may progress to ESKD and may require hemodialysis access in the future should be identified early so that they can be provided with timely education regarding vessel preservation. This includes patients with stage 3 to stage 5 CKD, patients already on kidney replacement therapy such as hemodialysis or peritoneal dialysis, and patients who have a functional transplanted kidney. Such patients should be encouraged to advocate to preserve their vessels and work with the treatment team in balancing the risks and benefits of every intervention, including blood draws and use of IV and arterial devices.4,9 Medical alert bracelets and signs at the bedside of hospitalized patients with CKD indicating the need to restrict needle use is essential in educating and alerting the medical community.4

It has also been proposed that a nephrology consult be requested before placing a PICC in patients with advanced CKD (stages 3–5).12 Patients and health professionals are encouraged to visit the website www.saveyourvein.org to further educate themselves on the importance of vein preservation.2

DISCLOSURES

The authors report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.

  • Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Dumaine C,
    2. Kiaii M,
    3. Miller L, et al
    . Vascular access practice patterns in Canada: a national survey. Can J Kidney Health Dis 2018; 5:2054358118759675. doi:10.1177/2054358118759675
    OpenUrlCrossRef
  2. ↵
    1. Lok CE,
    2. Huber TS,
    3. Lee T, et al
    . KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis 2020; 75(4 suppl 2):S1–S164. doi:10.1053/j.ajkd.2019.12.001
    OpenUrlCrossRefPubMed
  3. ↵
    1. Shingarev R,
    2. Allon M
    . Peripherally inserted central catheters and other intra-vascular devices: how safe are they for hemodialysis patients? Am J Kidney Dis 2012; 60(4):510–513. doi:10.1053/j.ajkd.2012.07.003
    OpenUrlCrossRefPubMed
  4. ↵
    1. Vachharajani TJ,
    2. Hassanein M,
    3. Liaqat A,
    4. Haddad N
    . Vessel preservation in chronic kidney disease. Adv Chronic Kidney Dis 2020; 27(3):177–182. doi:10.1053/j.ackd.2020.03.006
    OpenUrlCrossRef
  5. ↵
    1. Allen AW,
    2. Megargell JL,
    3. Brown DB, et al
    . Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol 2000; 11(10):1309–1314. doi:10.1016/s1051-0443(07)61307-4
    OpenUrlCrossRefPubMed
  6. ↵
    1. Chopra V,
    2. Flanders SA,
    3. Saint S
    . The problem with peripherally inserted central catheters. JAMA 2012; 308(15):1527–1528. doi:10.1001/jama.2012.12704
    OpenUrlCrossRefPubMed
  7. ↵
    1. El Ters M,
    2. Schears GJ,
    3. Taler SJ, et al
    . Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients. Am J Kidney Dis 2012; 60(4):601–608. doi:10.1053/j.ajkd.2012.05.007
    OpenUrlCrossRefPubMed
  8. ↵
    1. McGill RL,
    2. Ruthazer R,
    3. Meyer KB,
    4. Miskulin DC,
    5. Weiner DE
    . Peripherally inserted central catheters and hemodialysis outcomes. Clin J Am Soc Nephrol 2016; 11(8):1434–1440. doi:10.2215/CJN.01980216
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Saad T
    . Vein preservation and alternative venous access. Endovasc Today 2008; 32–36. https://evtoday.com/articles/2008-june/EVT0608_03-php. Accessed July 14, 2021.
  10. ↵
    1. Bhutani G,
    2. El Ters M,
    3. Kremers WK, et al
    . Evaluating safety of tunneled small bore central venous catheters in chronic kidney disease population: a quality improvement initiative. Hemodial Int 2017; 21(2):284–293. doi:10.1111/hdi.12484
    OpenUrlCrossRef
  11. ↵
    1. Sasadeusz KJ,
    2. Trerotola SO,
    3. Shah H, et al
    . Tunneled jugular small-bore central catheters as an alternative to peripherally inserted central catheters for intermediate-term venous access in patients with hemodialysis and chronic renal insufficiency. Radiology 1999; 213(1):303–306. doi:10.1148/radiology.213.1.r99se12303
    OpenUrlCrossRefPubMed
  12. ↵
    1. Williams AW,
    2. Dwyer AC,
    3. Eddy AA, et al
    . Critical and honest conversations: the evidence behind the ‘Choosing Wisely’ campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol 2012; 7(10):1664–1672. doi:10.2215/CJN.04970512
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 88 (8)
Cleveland Clinic Journal of Medicine
Vol. 88, Issue 8
1 Aug 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
Nora Hilda Hernandez Garcilazo, Mohamed Hassanein, Tushar J. Vachharajani, Evamaria Anvari
Cleveland Clinic Journal of Medicine Aug 2021, 88 (8) 431-433; DOI: 10.3949/ccjm.88a.20173

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
Nora Hilda Hernandez Garcilazo, Mohamed Hassanein, Tushar J. Vachharajani, Evamaria Anvari
Cleveland Clinic Journal of Medicine Aug 2021, 88 (8) 431-433; DOI: 10.3949/ccjm.88a.20173
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • PICC PROS: CONVENIENCE, LOW COST
    • PICC CONS: BLOOD VESSEL RISKS
    • CASE CONTINUED
    • PICC ALTERNATIVES
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
  • Do I need to treat supine hypertension in my hospitalized patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Hospital Medicine
  • Nephrology
  • Vascular Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire